Elora J. Khan Foundation Joins CBTN as its Newest Champion
Foundation Supports CBTN Initiative to Accelerate Pediatric Brain Tumor Research Through Collaboration and Advocacy
The announcement coincides with Elora Joyce Khan Pediatric Brain Cancer Awareness Day, recognized across
"Joining CBTN as a Champion felt deeply aligned with the vision we have for the foundation because collaboration is essential in pediatric brain cancer research," said
The Elora J. Khan Foundation was created following Elora's passing to support families through advocacy, direct assistance, community outreach, and research collaboration.
"The Elora J. Khan Foundation has transformed loss into meaningful action for children and families facing pediatric brain tumors," said
About the Elora J. Khan Foundation
The Elora J. Khan Foundation is a 501(c)(3) nonprofit organization created in honor of
About the Children's Brain Tumor Network
The Children's Brain Tumor Network (CBTN) is a global research community accelerating discovery for children and young adults with brain tumors. CBTN provides harmonized clinical and genomic data, biospecimens, imaging, and preclinical models through cloud-enabled platforms that support real-time collaboration across institutions and disciplines. Learn more at CBTN.org.
Media Contact
Emily Reed
Children's Brain Tumor Network
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/elora-j-khan-foundation-joins-cbtn-as-its-newest-champion-302798194.html
SOURCE Children’s Brain Tumor Network
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jardins d'Arménie Selected to Bring Luxury Armenian Brandy to Exclusive Pre-Emmys Celebrity Gifting Lounge in Los Angeles
- MAJOR LEAGUE TABLE TENNIS ANNOUNCES LEAGUE'S MOST EXPANSIVE MEDIA DISTRIBUTION LINEUP
- Implantica's Capital Markets Day webcast available on demand
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share